期刊
EXPERIMENTAL NEUROLOGY
卷 239, 期 -, 页码 133-138出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.expneurol.2012.10.007
关键词
-
资金
- NATIONAL INSTITUTE ON AGING [R01AG020335, P01AG000538] Funding Source: NIH RePORTER
- NIA NIH HHS [R01AG20335, AG00538] Funding Source: Medline
Alzheimer disease (AD) is the most prevalent cause of dementia in humans, and the symptoms are commonly manifested after the seventh decade of life. Numerous pathological changes have been described in the post-mortem brains of AD patients, including senile plaques, neurofibrillary tangles, neuroinflammation, synapse loss, and neuronal death. Reactive astrocytes surrounding senile plaques seem to be responsible for the on-going inflammatory process in the disease through the release of cytokines and other toxic products. However, little is known about the regulation of these cells in the AD brain. Here we discuss the potential translational impact of the recent findings of Carrero and colleagues, published in Experimental Neurology, that shows the underlying molecular mechanism of astrocyte activation in response to beta-amyloid (A beta). Like-wise, the relevance of pro-inflammatory mediators tumor necrosis factor-alpha (TNF-alpha), interleukin-beta (IL-1 beta), cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-kappa B), as integral players in disease progression will be discussed. (c) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据